Cellomics

100 Technology Drive,
Pittsburgh,
PA 15219
United States of America
Tel: +1 412-770-2200
Fax: +1 412-770-2450
Email Us

Print Email to a friend

Cellomics, Inc. is automating drug discovery through a unique, cell-based assay platform that addresses the needs of Drug Discovery and Systems Biology groups by offering complete systems for High Content Screening (HCS). The platform includes HCS instrumentation, informatics, cellular image analysis software (BioApplications), fluorescent reagents, kits, cell lines, and multiparametric assays. When applied to early drug discovery, this platform is proving to reduce the 'idea-to-discovery' cycle time in drug discovery, while increasing the probability of the therapeutic success of leads as well as enhancing throughput in systems biology and basic research.

Further Information: http://www.cellomics.com/



Related Products

Fisher Unit, Cellomics, Launches VTI Live
The ArrayScan® VTI High-Content Screening Reader offers customers the ability to run automated live-cell kinetic assays.

Cellomics Introduces Neuronal Profiling BioApplication
The software provides real-time analysis of nerve cell images.

Fisher Unit, Cellomics, Launches VTI Live
The ArrayScan® VTI High-Content Screening Reader offers customers the ability to run automated live-cell kinetic assays.

Cellomics Introduces Neuronal Profiling BioApplication
The software provides real-time analysis of nerve cell images.



Related news from our archive

Cellomics Offers Customers Expanded HCS Training Advanced Courses
These courses will offer customers training for specific uses in biology research and therapeutics.

Cellomics Confers with European Customers During HCS User Group Meeting in Dublin
60 customers shared their experiences with high content screening and analysis.

Cellomics Offers Customers Expanded HCS Training Advanced Courses
These courses will offer customers training for specific uses in biology research and therapeutics.

Cellomics Confers with European Customers During HCS User Group Meeting in Dublin
60 customers shared their experiences with high content screening and analysis.